research Evaluating the Therapeutic Potential of Ritlecitinib for the Treatment of Alopecia Areata
Ritlecitinib shows promise for hair regrowth in alopecia areata patients.
Search
forLearn
0 / 0 results — no results
Research
5 / 89 results
research Efficacy and Safety of the Oral Janus Kinase Inhibitor Baricitinib in the Treatment of Adults with Alopecia Areata: Phase 2 Results from a Randomized Controlled Study
Baricitinib is effective and safe for treating severe alopecia areata.
research Comparative Efficacy and Safety of Janus Kinase Inhibitors Used in Alopecia Areata: A Systematic Review and Meta-Analysis
Baricitinib and deuruxolitinib are effective for treating alopecia areata, but their efficacy depends on the dose.
research Effectiveness and Safety of Baricitinib in Severe Alopecia Areata: 48-Week Results
Baricitinib effectively promotes hair regrowth and improves well-being in severe alopecia areata patients.
research Effectiveness and Safety of Baricitinib in Severe Alopecia Areata: 48-Week Results
Baricitinib effectively promotes hair regrowth and improves well-being in severe alopecia areata patients.
Community Join
0 / 0 results — no results